Comment: Mylan homes in on EU approval for Meda deal by late July
Generic drugmaker Mylan can expect to receive EU approval to buy Swedish rival Meda before the end of next month. The European Commission currently has until July 6 to rule on...To view the full article, register now.
Already a subscriber? Click here to view full article